Faecal immunochemical testing and blood tests for prioritization of urgent colorectal cancer referrals in symptomatic patients: A 2-year evaluation

Abstract

Background: A novel pathway incorporating faecal immunochemical testing (FIT) for rapid colorectal cancer diagnosis (RCCD) was introduced in 2017. This paper reports on the service evaluation after 2 years of pathway implementation. Methods: The RCCD protocol was based on FIT, blood results and symptoms to stratify adult patients in primary care. Two-weekwait (2WW) investigation was indicated for patients with rectal bleeding, rectal mass and faecal haemoglobin (fHb) level of 10 μg Hb/ g faeces or above or 4 μg Hb/g faeces or more in the presence of anaemia, low ferritin or thrombocytosis, in all other symptom groups. Patients with 100 μg Hb/g faeces or above had expedited investigation. A retrospective audit of colorectal cancer detected between 2017 and 2019 was conducted, fHb thresholds were reviewed and critically assessed for cancer diagnoses. Results: In 2 years, 14788 FIT tests were dispatched with 13361 (90.4 per cent) completed returns. Overall, fHb was less than 4 μg Hb/g faeces in 9208 results (68.9 per cent), 4-9.9 μg Hb/g in 1583 (11.8 per cent), 10-99.9 μg Hb/g in 1850 (13.8 per cent) and 100 μg Hb/g faeces or above in 720 (5.4 per cent). During follow-up (median 10.4 months), 227 colorectal cancers were diagnosed. The cancer detection rate was 0.1 per cent in patients with fHb below 4 μg Hb/g faeces, 0.6 per cent in those with fHb 4-9.9 μg Hb/g faeces, 3.3 per cent for fHb 10-99.9 μg Hb/g faeces and 20.7 per cent for fHb 100 μg Hb/g faeces or above. The detection rate in the cohort with 10-19.9 μg Hb/g faeces was 1.4 per cent, below the National Institute for Health and Care Excellence threshold for urgent referral. The colorectal cancer rate in patients with fHb below 20 μg Hb/g faeces was less than 0.3 per cent. Conclusion: Use of FIT to "rule out"urgent referral from primary care misses a small number of cases. The threshold for referral may be adjusted with blood results to improve stratification.